Founders Financial Securities LLC Amgen Inc Transaction History

Founders Financial Securities LLC

$1.06 Billion
Q3 2024

A detailed history of Founders Financial Securities LLC transactions in Amgen Inc stock. As of the latest transaction made, Founders Financial Securities LLC holds 5,043 shares of AMGN stock, worth $1.33 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

5,043

Previous 5,128 1.66%

Holding current value

$1.33 Million

Previous $1.6 Million 1.37%

% of portfolio

0.15%

Previous 0.15%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $26,297 - $28,677	-85 Reduced 1.66%	5,043 $1.62 Million
Q2 2024 Aug 02, 2024	BUY	$262.75 - $319.31 $2,102 - $2,554	8 Added 0.16%	5,128 $1.6 Million
Q1 2024 Apr 17, 2024	SELL	$268.87 - $324.56 $37,910 - $45,762	-141 Reduced 2.68%	5,120 $1.46 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $9,460 - $10,673	-37 Reduced 0.7%	5,261 $1.52 Million
Q3 2023 Oct 17, 2023	SELL	$218.65 - $271.46 $13,774 - $17,101	-63 Reduced 1.18%	5,298 $1.42 Million
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $47,139 - $55,741	220 Added 4.28%	5,361 $1.19 Million
Q1 2023 May 04, 2023	BUY	$225.79 - $275.2 $75,639 - $92,192	335 Added 6.97%	5,141 $1.24 Million
Q4 2022 Feb 08, 2023	SELL	$229.03 - $291.01 $79,244 - $100,689	-346 Reduced 6.72%	4,806 $1.26 Million
Q3 2022 Oct 27, 2022	BUY	$224.46 - $253.15 $15,712 - $17,720	70 Added 1.38%	5,152 $1.16 Million
Q2 2022 Jul 27, 2022	BUY	$230.71 - $256.74 $6,459 - $7,188	28 Added 0.55%	5,082 $1.24 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $98,671 - $109,156	450 Added 9.77%	5,054 $1.22 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $39,179 - $44,837	197 Added 4.47%	4,604 $1.04 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $326,471 - $382,500	-1,538 Reduced 25.87%	4,407 $937,000
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $132,673 - $147,191	568 Added 10.56%	5,945 $1.45 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $108,070 - $125,938	487 Added 9.96%	5,377 $1.34 Million
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $1.06 Million - $1.26 Million	4,890 New	4,890 $1.12 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $1.49 Million - $1.65 Million	-6,339 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $133,323 - $163,606	674 Added 11.9%	6,339 $1.5 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $24,966 - $33,112	137 Added 2.48%	5,665 $1.15 Million
Q4 2019 Feb 11, 2020	SELL	$189.21 - $243.2 $3,216 - $4,134	-17 Reduced 0.31%	5,528 $1.33 Million
Q3 2019 Oct 17, 2019	BUY	$174.11 - $208.62 $51,188 - $61,334	294 Added 5.6%	5,545 $1.07 Million
Q2 2019 Jul 22, 2019	BUY	$166.7 - $195.41 $875,341 - $1.03 Million	5,251 New	5,251 $968,000
Q3 2018 Oct 17, 2018	SELL	$185.29 - $208.89 $1.07 Million - $1.21 Million	-5,788 Closed	0 $0
Q2 2018 Jul 18, 2018	SELL	$166.05 - $186.51 $12,785 - $14,361	-77 Reduced 1.31%	5,788 $1.07 Million
Q1 2018 Apr 24, 2018	BUY	$169.43 - $198.0 $378,506 - $442,332	2,234 Added 61.53%	5,865 $1 Million
Q4 2017 Jan 25, 2018	BUY	$168.79 - $188.59 $612,876 - $684,770	3,631	3,631 $631,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Financial Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Founders Financial Securities LLC with notifications on news.

Account

Founders Financial Securities LLC Amgen Inc Transaction History